322 related articles for article (PubMed ID: 12489031)
1. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
2. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
3. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
4. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector.
Tsuda H; Wada T; Ito Y; Uchida H; Dehari H; Nakamura K; Sasaki K; Kobune M; Yamashita T; Hamada H
Mol Ther; 2003 Mar; 7(3):354-65. PubMed ID: 12668131
[TBL] [Abstract][Full Text] [Related]
5. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
Hiwasa K; Nagaya H; Terao S; Acharya B; Hamada K; Mizuguchi H; Gotoh A
Anticancer Res; 2012 Aug; 32(8):3137-40. PubMed ID: 22843884
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
Lalonde ES; Beyer G; Friedlander PL; Kolls JK
Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
[TBL] [Abstract][Full Text] [Related]
7. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Kasono K; Blackwell JL; Douglas JT; Dmitriev I; Strong TV; Reynolds P; Kropf DA; Carroll WR; Peters GE; Bucy RP; Curiel DT; Krasnykh V
Clin Cancer Res; 1999 Sep; 5(9):2571-9. PubMed ID: 10499635
[TBL] [Abstract][Full Text] [Related]
8. Improved gene transfer into renal carcinoma cells using adenovirus vector containing RGD motif.
Terao S; Acharya B; Suzuki T; Aoi T; Naoe M; Hamada K; Mizuguchi H; Gotoh A
Anticancer Res; 2009 Aug; 29(8):2997-3001. PubMed ID: 19661307
[TBL] [Abstract][Full Text] [Related]
9. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
[TBL] [Abstract][Full Text] [Related]
10. A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis.
Bakker AC; Van de Loo FA; Joosten LA; Bennink MB; Arntz OJ; Dmitriev IP; Kashentsera EA; Curiel DT; van den Berg WB
Gene Ther; 2001 Dec; 8(23):1785-93. PubMed ID: 11803398
[TBL] [Abstract][Full Text] [Related]
11. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
12. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
13. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
Tsuda H; Wada T; Yamashita T; Hamada H
J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
15. Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency.
Wu H; Seki T; Dmitriev I; Uil T; Kashentseva E; Han T; Curiel DT
Hum Gene Ther; 2002 Sep; 13(13):1647-53. PubMed ID: 12228019
[TBL] [Abstract][Full Text] [Related]
16. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
17. Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.
Logunov DY; Zubkova OV; Karyagina-Zhulina AS; Shuvalova EA; Karpov AP; Shmarov MM; Tutykhina IL; Alyapkina YS; Grezina NM; Zinovieva NA; Ernst LK; Gintsburg AL; Naroditsky BS
J Virol; 2007 Sep; 81(18):9641-52. PubMed ID: 17596306
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.
Toh ML; Hong SS; van de Loo F; Franqueville L; Lindholm L; van den Berg W; Boulanger P; Miossec P
J Immunol; 2005 Dec; 175(11):7687-98. PubMed ID: 16301679
[TBL] [Abstract][Full Text] [Related]
19. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
[TBL] [Abstract][Full Text] [Related]
20. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]